When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“When is thrombophilia testing appropriate and how can the evidence help guide clinical care?
In this expert panel from World Thrombosis Day, presented in partnership with Sysmex Europe, leading voices in thrombosis explore evidence based approaches to thrombophilia screening and management.
Featuring Lana Castellucci, and Cihan Ay, with moderator Andreas Rechner, the discussion covers hereditary thrombophilia, Factor V Leiden, antiphospholipid syndrome (APS), appropriate testing, clinical management and future directions in thrombosis care.
Watch the full 45 minute discussion and deepen your understanding of this evolving area of thrombosis care.”
Stay updated with Hemostasis Today.
-
Sep 9, 2026, 16:07Zahra Safarzadeh: From Novel F8 Variant to Clinical Significance
-
Sep 9, 2026, 16:00Maximo Agustin Schiavone: HDL Beyond Cholesterol – Linking Lipids and Immunity
-
Sep 9, 2026, 15:56Abdul Mannan: When Antiseizure Drugs Alter DOAC Risk
-
Sep 9, 2026, 15:39Alessandro Lucchesi: The Future of MPN Disease Modification
-
Sep 9, 2026, 15:10Pablo Corral: Is the Lp(a) Hypothesis Wrong?
-
Sep 9, 2026, 14:54Agnes Kisakye: Expanding Point-of-Care Ultrasound and Surgical Interventions for Hemophilia in Uganda
-
Sep 9, 2026, 14:52Jan Sloves: Addressing Diagnostic and Treatment Variability in Pelvic-Origin Varicose Veins
-
Sep 9, 2026, 14:48The French Care Pathway for Gene Therapy in Haemophilia B – CRH French Reference Center for Hemophilia Lyon
-
Sep 9, 2026, 14:43David McIntosh: The Ethics of Plasma Donation